ME AWARENESS 2026

Campaigning

M.E awareness for 2026

Awareness helps in several ways: it educates the public and healthcare providers, reducing stigma and promoting early diagnosis; it drives funding for research into causes and treatments, as there’s currently no cure; and it fosters empathy and support for those living with ME, who often feel isolated due to the condition’s impact on their daily lives. By shining a light on ME, we can improve quality of life for millions and push for better medical and social resources.

M.E Awareness

raising awareness for 2026

Raising awareness for Myalgic Encephalomyelitis (ME), also called Chronic Fatigue Syndrome (CFS), is vital because it’s a misunderstood and often invisible illness. ME is a severe, chronic condition that impacts multiple body systems, leading to extreme fatigue, pain, brain fog, and post-exertional malaise—where even small activities worsen symptoms.

Severe M.E awareness

This Years Focus

Inspirational word 'Advice' written in white chalk on blackboard.

May ME Awareness Month

As part of M.E. Awareness Month this May, we’re pleased to share a new resource created especially for people living with severe and very severe ME, as well as those who support and care for them. This short document explains, in clear everyday language, what severe ME really is, why it requires such careful handling, and how the right approaches can dramatically reduce harm and distress. Many people with severe or very severe ME are unable to speak for themselves, advocate for their needs, or correct the misunderstandings that too often surround this illness — which is why this resource is designed to do that work on their behalf.
The guidance sets out practical, straightforward ways that carers, family members, friends, visiting professionals, home‑care staff and medical teams can support someone safely. It covers the essential principles of reducing sensory input, avoiding over‑exertion, recognising post‑exertional malaise, removing unnecessary demands, and prioritising calm, quiet, low‑stimulus environments. It also includes clear reminders of what not to do — such as encouraging exercise, suggesting therapy as a cure, or assuming the illness is psychological. These points are especially important for those who are new to ME or who may only have seen outdated or inaccurate information.
We encourage our members to share this document with anyone involved in their care or daily life — whether that’s a GP, consultant, community nurse, home‑care provider, social worker, family members, friends, neighbours, or support staff. You may also wish to send it to schools or colleges where appropriate, or anyone else who needs to understand the realities of severe ME and the absolute importance of minimising harm. Sometimes a single clear explanation can transform how someone interacts with a person living with this condition.
This resource is designed to act as a shield as much as a guide — helping reduce misunderstanding, preventing unintentional harm, and giving your wider circle the confidence to support you safely. It’s a simple tool with a big purpose: protecting energy, reducing pressure, and making day‑to‑day life a little easier for those who live with the most severe forms of ME.
You’ll find the full document enclosed. Please feel free to pass it on to anyone who may benefit from reading it.
 

Chalkboard with the word 'Support' written in white chalk on a black background.

GAME ME-ICC 

A very important observation in ME (Myalgic Encephalomyelitis, especially ME-ICC). There’s growing evidence that post-exertional changes in ME patients are highly individualized at the molecular level, even if the clinical outcome like fatigue or post-exertional malaise is similar.
Exercise as a Molecular Stress Test
* In research, exercise (often a cardiopulmonary exercise test or CPET) is used as a stress challenge to reveal hidden dysfunctions.
* For ME patients, this isn’t just physical fatigue. It triggers neuroimmune, metabolic, and transcriptional changes.
* Studies show that the same exercise can provoke very different molecular responses in different patients, even if their symptoms look similar.
Implications
* Heterogeneity explains why a one-size-fits-all treatment fails. Molecular data show ME is not a single disease mechanism but a spectrum of dysregulations.
* Potential for molecular subtyping: Patients could be grouped by their molecular response profile, e.g., immune-dominant vs. metabolism-dominant post-exertional changes.
* Relevance to post-exertional Neuroimmune exhaustion (PENE). The individualized molecular changes correlate with severity and type of PENE , explaining why two patients can do the same exercise but have very different symptom profiles afterwards.
4. Supporting Studies
*Light et al., 2012 – Gene expression in immune cells shows distinct post-exercise transcriptional changes in ME patients versus controls. Some patients had dramatic upregulation of stress and inflammation genes, others had muted responses. https://pmc.ncbi.nlm.nih.gov/articles/PMC3175315/
*Armstrong et al., 2015 – Metabolomic profiling found heterogeneous post-exercise changes in energy metabolites. https://findanexpert.unimelb.edu.au/…/981475-metabolic…
*/Naviaux et al., 2016 (metabolic network analysis) – Suggests ME patients’ metabolic responses to stress are individualized “cell danger response” profiles. https://pubmed.ncbi.nlm.nih.gov/27573827/
Bottom line: ME patients respond differently at a molecular level to exercise due to heterogeneity in immune, metabolic, and mitochondrial pathways. This heterogeneity is why exercise testing can uncover disease mechanisms but also why patients’ post-exertional experiences are so variable.
#GAME
#NightingaleContinuum

Thanks to Wendy Boutilier

Yellow sign with text questions and answers suggesting direction in decision-making.

“This is not a psychological disease”

Thanks to Broken Battery
Professor Chris Ponting on the 116 blood molecule differences his team found in people with #MECFS
“This is not a psychological disease” people did not alter their blood molecules just to “spook the psychiatrists”.
Clip from Hope 4 ME & Fibro NI 2026

Chalkboard with the word 'Support' written in white chalk on a black background.

NEW RESOURCE FOR PATIENTS – M.E. Clinical Update Cards

These business cards have been designed for people living with M.E. to hand directly to their GP, hospital doctor, nurse or other healthcare professional.
This idea came from one of our severe M.E. members, Neil McCalmont, following several recent hospital admissions where a lack of knowledge about M.E. became very clear.
The cards direct healthcare professionals to a free, evidence-based 1-hour M.E. Clinical Update webinar, Hope 4 ME & Fibro N.I. developed in partnership with General Practice Northern Ireland (GPNI)
🔹 The QR code on the front takes GPNI members directly to the clinical update.
🔹 Non-GPNI members — any healthcare professional — can use the QR code on the back to request the webinar access code.
The card also highlights the importance of:
• Recognising post-exertional malaise (PEM)
• Avoiding harm
• Ensuring safe, appropriate management
Sometimes advocacy looks like a protest.
Sometimes it looks like quietly placing a card on a desk and saying, “Please take a look at this.”
A massive thank you to our member Neil 💙
Details to follow on how these cards can be ordered to keep handy in your purse or wallet.
Full details and credits on the GPNI Clinical Update here – https://www.hope4mefibro.org/gpni-me-webinar
Design by colincranney.com
#myalgicEncephalomyelitis #MECFS #PatientSafety #EducationMatters #Hope4ME #volunteers #PatientsHelpingPatients

Inspirational word 'Advice' written in white chalk on blackboard.

The Nightingale Continuum

People with ME/ICC often describe a progressive loss of functional capacity that can feel like “fading away,” as the illness steadily reduces energy availability, cognitive endurance, and physical tolerance. This is not simple fatigue, but a systemic impairment of energy production and recovery, where even minimal exertion can lead to disproportionate and prolonged deterioration rather than normal recovery. Over time, patients may be forced into an ever-narrowing envelope of tolerable activity, with a marked reduction in baseline function and increasing loss of independence.
Despite growing biomedical evidence, ME/ICC remains widely under-recognised in clinical practice. Many clinicians receive limited training in the condition, and its complex, multi-system nature combined with the lack of consistent routine biomarkers can contribute to misinterpretation of symptoms and underestimation of severity. As a result, patients are frequently dismissed or not fully believed, not necessarily due to intent, but due to persistent gaps in clinical understanding and outdated assumptions about the illness.
Closing the gap in ME/ICC care requires action at several levels; clinical education, diagnostics, healthcare systems, and patient protection. The key is shifting from misunderstanding and variability in practice toward consistency, validation, and biomedical literacy.
At the clinical level, a major step is improving medical education. ME/ICC needs to be properly integrated into undergraduate medical training, postgraduate programs, and continuing professional development. This includes teaching the ICC/updated biomedical models, post-exertional Neuroimmune exhaustion, autonomic and immune involvement, and the harms of inappropriate “graded exercise” approaches. Clinicians don’t just need awareness, they need practical competence in recognition and safe management.
Diagnosis is another critical gap. Earlier and more consistent use of validated diagnostic criteria, combined with structured clinical assessment tools, would reduce misdiagnosis and delay. Clinicians also need guidance on excluding common mimics while recognising that standard investigations can appear normal despite significant disability.
On the system side, care pathways should be formalised so patients are not left navigating fragmented services. Multidisciplinary models that include neurology, immunology, cardiology (for orthostatic intolerance), and rehabilitation medicine, grounded in energy-limiting principles, can reduce harm and improve continuity of care. Access to disability supports should also be based on functional impairment rather than fluctuating day-to-day presentation.
Equally important is shifting the clinical culture: validating patient-reported symptoms as clinically meaningful data, not subjective noise. ME/ICC is one of the conditions where patient history is central to diagnosis, and failing to treat it as such perpetuates under-recognition.
Finally, research investment needs to focus on proper stratification, objective biomarkers, metabolic dysfunction, neuroimmune dysregulation, and post-exertional pathophysiology. Without measurable biological targets, clinical uncertainty will continue to feed inconsistency in care.
In short, closing the gap means better education, clearer diagnostic practice, safer care pathways, and a stronger commitment to biomedical research paired with a cultural shift toward taking patient experience seriously as evidence, not opinion.
https://pmc.ncbi.nlm.nih.gov/articles/PMC12346739/….
https://pmc.ncbi.nlm.nih.gov/articles/PMC3973969/….
https://www.sciencedirect.com/…/abs/pii/S0002934325000932
https://www.healthlinkbc.ca/…/myalgic…
https://pmc.ncbi.nlm.nih.gov/articles/PMC3973969/….
#NightingaleContinuum
#GAMEICC

Yellow sign with text questions and answers suggesting direction in decision-making.

Investigating the ME/CFS experience through qualitative analysis of memorial entries

Abstract
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is an impairing chronic condition characterized by exhaustion and worsening symptoms following exertion, often accompanied by pain, sleep issues, and cognitive issues. Historically, ME/CFS was not considered to be linked to mortality, however, more recent studies have questioned this assumption. The National Chronic Fatigue and Immune Dysfunction Syndrome (CFIDS) Foundation maintains a memorial list consisting of deceased individuals who had ME/CFS. This secondary qualitative thematic analysis analyzed 505 entries on the National CFIDS Foundation memorial list, inductively developing a codebook from the publicly available memorial records. Two coders independently coded each entry before meeting to develop themes that incorporated the understanding of each coder. Themes emerged within four societal levels: systemic neglect and institutional failure; clinical neglect and failures; social disconnection and advocacy; and personal burden and quality of life. Describing systemic neglect and institutional failure, entries recounted a lack of acknowledgement by health, insurance, and disability authorities, as well as a lack of investment in research and treatment of ME/CFS at the federal level. Negative healthcare experiences included misdiagnosis and misattribution of symptoms, dismissal, inadequate knowledge and experience with treating ME/CFS, and the recommendation of unhelpful treatments. The disbelief and misattribution by acquaintances described in the entries contributed to feelings of social isolation, leading some to turn to advocacy work and support groups. Entries also described the individual impact of the condition, including functional impairments, the impact of symptoms, management strategies, financial stress, and mental health symptoms. Some deaths were directly and indirectly attributed to ME/CFS by individuals with ME/CFS and their acquaintances. This analysis provides a glimpse of the lived experience as well as death of individuals with ME/CFS through the lens of acquaintances of the deceased, emphasizing the substantial impact of the condition..

Inspirational word 'Advice' written in white chalk on blackboard.

The prodromal phase in Myalgic Encephalomyelitis (ME)

The prodromal phase in Myalgic Encephalomyelitis (ME), as described in the International Consensus Criteria (ICC) context, refers to the early period before the illness becomes fully established, when initial symptoms begin to appear but may not yet meet full diagnostic criteria.
In ME, this phase is often triggered by an infection or other physiological stressor (commonly viral, such as EBV), and can include symptoms like profound fatigue, flu-like malaise, sore throat, lymph node tenderness, cognitive fog, sleep disruption, and autonomic changes. What distinguishes the prodromal stage in ME is that it’s not just a typical recovery period—it reflects the early breakdown of homeostasis, where immune, neurological, and metabolic systems begin to dysregulate.
Within the ICC framework, the prodromal period is important because it can mark the transition into a chronic, neuroimmune disease state. Early signs of post-exertional neuroimmune exhaustion (PENE) may begin to appear, even if subtly, and the body’s ability to recover from exertion becomes impaired. In some cases, what looks like a prolonged “post-viral” illness is actually this prodromal stage evolving into established ME.
Not everyone experiences a clearly defined prodrome, but when present, it can last weeks to months before the illness stabilizes into its more persistent pattern.
…..
These terms get mixed together a lot, but in ME (especially under the ICC), they describe different points and patterns in the illness:
Prodromal phase (early onset period)
This is the lead-in to the illness. It usually follows an infection or major stressor and looks like a prolonged “not recovering properly” phase. Symptoms are building—fatigue, flu-like feelings, cognitive issues, sleep disruption – but may not yet meet full ME criteria. The key feature is progression: the body is losing its ability to return to baseline, and early signs of post-exertional worsening may start to show.
Established ME (meeting ICC criteria)
This is when the illness has fully declared itself, with hallmark features like post-exertional neuroimmune exhaustion (PENE), neurological impairment, immune dysfunction, and energy metabolism issues. Symptoms are more consistent and reproducible, especially the abnormal response to exertion.
Relapse (or “crash”)
A relapse happens after ME is established. It’s a worsening of symptoms triggered by exertion or stress – physical, cognitive, or sensory. The defining feature is that even small efforts can lead to a disproportionate, delayed, and prolonged symptom flare. Unlike the prodromal phase, a relapse is not the start of the illness – it’s a flare within it.
Remission
Remission means symptoms improve significantly, sometimes to the point where a person can function relatively well. However, the underlying vulnerability usually remains. People in remission can still relapse if they exceed their energy limits, so it’s not considered a full cure.
Post-viral fatigue (PVF)
This is often confused with early ME. PVF is a temporary recovery phase after an infection, where fatigue and weakness linger but gradually improve over time. The key difference is that PVF does not involve the persistent, pathological post-exertional response (PENE) seen in ME, and people steadily return to baseline rather than deteriorating or plateauing.
In short:
* Prodromal = onset and progression toward ME
* ME (ICC) = established, multi-system disease with PENE
* Relapse = flare within the illness
* Remission = partial or temporary improvement
* Post-viral fatigue = gradual recovery, not chronic dysfunction
References
https://pmc.ncbi.nlm.nih.gov/articles/PMC8201170/….
https://pmc.ncbi.nlm.nih.gov/articles/PMC7431524/….
www.mesocietyedmonton.org.
https://www.cdc.gov/…/hcp/clinical-overview/index.html….
https://pmc.ncbi.nlm.nih.gov/articles/PMC8835111/…(0–4%20Months,body%20(42–45).
https://me-pedia.org/wiki/Myalgic_encephalomyelitis….
https://www.frontiersin.org/…/10…/fneur.2020.00826/full
https://cdn.clinicaltrials.gov/…/NCT02…/Prot_SAP_000.pdf
https://www.researchgate.net/…/352195539_Warning…
#NightingaleContinuum
#GAMEICC

Chalkboard with the word 'Support' written in white chalk on a black background.

Grieving the life you had before M.E

Grieving the life you had before M.E. (as defined by the ICC) is not a side issue of the illness – it is often one of its central, ongoing experiences. What makes this grief particularly complex is that it isn’t tied to a single loss or a clear endpoint. Instead, it unfolds in layers: the loss of physical capacity, cognitive clarity, independence, spontaneity, identity, roles, relationships, and the future you once assumed was yours. And unlike many forms of grief, there may be no socially recognized rituals, no clear validation from others, and no predictable resolution.
Before illness, life often ran on an invisible foundation of reliability – you think, and your brain responds; you move, and your body follows; you plan, and there’s a reasonable expectation those plans can happen. M.E. disrupts that contract. The body becomes unpredictable, sometimes unresponsive, sometimes actively resistant. Post-exertional neuroimmune exhaustion (PENE) means that even small activities can carry disproportionate consequences, making everyday decisions feel loaded with risk. Over time, this reshapes how you relate to your own body – not as something you can trust, but something you must constantly negotiate with.
This grief is often misunderstood and, at times, wrongly dismissed as psychosomatic or purely psychological. It is not. The losses in M.E. are concrete and lived: the inability to sustain activity without physiological consequence, the collapse of stamina, cognitive dysfunction, and the enforced limits on even basic daily functioning. The emotional response to these changes is not the cause of the illness – it is the consequence of it. What many people experience is closer to the aftermath of a sudden, life-altering disruption than a mood disorder arising in isolation—a sense of being abruptly cut off from a previous life, followed by the ongoing work of navigating a body that no longer functions predictably or reliably.
There is also a profound identity shift. Many people with M.E. were previously active, engaged, capable – often the ones others relied on. Losing the ability to fulfill those roles can create a deep sense of disorientation. Who are you when you can no longer do the things that once defined you? This isn’t a superficial question. It can touch every aspect of self-concept: competence, purpose, worth, and belonging. The outside world may continue moving at full speed, while your own life narrows, sometimes drastically, creating a painful contrast between “before” and “now.”
The social dimension of this grief is often underestimated. Friendships can change or fade – not always out of lack of care, but because the rhythms of your life no longer align. Invitations may stop. Conversations can become strained when your reality is difficult to explain or is misunderstood. Some people encounter disbelief or minimization, which adds another layer: not just grief for what’s lost, but for not being fully seen in that loss. Loneliness, in this context, isn’t simply about being alone, it’s about being out of sync with a world that no longer fits.
There’s also anticipatory grief – the quiet, persistent awareness of what might not be possible in the future. Careers, travel, family plans, personal ambitions – all can feel uncertain or out of reach. And because M.E. can fluctuate, hope and loss often coexist in a kind of tension. A slightly better day might bring a glimpse of your old self, followed by a crash that reinforces the limits. This cycle can make the grieving process feel circular rather than linear.
Importantly, grief in M.E. doesn’t follow neat stages. It can show up as sadness, frustration, anger, numbness, or even guilt—guilt for resting, for needing help, for not being who you used to be. Some days it may feel sharp and present; other days it sits quietly in the background. None of these responses are signs of weakness – they are understandable reactions to a profound, ongoing loss.
Over time, some people find ways to relate differently to this grief. Not by “getting over” the life they had, but by slowly integrating the reality of their current one. This might involve redefining value and meaning in smaller, more contained ways. It might mean recognizing resilience not in pushing through, but in respecting limits. It might involve finding connection with others who understand the illness, where less explanation is needed. These shifts don’t erase the loss – but they can soften the edges of it.
There can also be a quiet rebuilding of identity. While many aspects of the old life may no longer be accessible, the core of who you are – your perceptions, your values, your way of relating to others – still exists, even if it now expresses itself differently. Some people discover forms of creativity, insight, or connection that were less visible before, not as a replacement for what was lost, but as something that coexists alongside it.
Grief for your old life in M.E. is not something to rush or resolve. It is a natural response to a life-altering condition that affects nearly every domain of existence. Acknowledging it – without minimizing it or trying to force it into a tidy narrative – is often one of the most honest and stabilizing things you can do.
@wendyboutilier
#NightingaleContinuum
#GAMEICC

Simple and minimalist image featuring the phrase 'Medical Research' against a light blue background.

Muscle weakness and atrophy in ME

Muscle weakness and atrophy in ME are not due to deconditioning alone. Evidence suggests they are driven by underlying physiological dysfunction – particularly impaired energy metabolism, mitochondrial abnormalities, and altered blood flow, combined with reduced activity resulting from post-exertional symptom exacerbation.
Key Aspects of Muscle Waste in ME:
* Muscle Metabolism Defects: Studies show significant muscle bioenergetic failure, including prolonged recovery after exercise, increased intramuscular acidosis, and rapid phosphorus depletion.
* Mitochondrial Dysfunction: Muscle cells in ME struggle to produce sufficient ATP (energy), which can lead to structural damage and metabolic stress in muscle cells.
* Reduced Muscle Strength: Handgrip and quadriceps strength are often significantly reduced, which correlates with overall lower physical performance.
* Muscle Fibers: Research suggests ME muscle tissues may have fewer capillaries and a higher proportion of rapidly fatiguing glycolytic fibers, which differ from typical bed-rest atrophy.
* Severe Cases: In severe cases, muscle wasting becomes more pronounced due to prolonged inactivity, making the management of mobility essential to prevent further loss.
Potential Causes and Contributing Factors:
* Reduced Activity (Deconditioning): While not the only cause, the high level of fatigue forces many to become sedentary, leading to secondary loss of muscle mass.
* Autonomic Dysfunction: Dysfunction in the nervous system might affect motor control and muscle activation.
* Autoantibodies: Some evidence suggests antibodies may damage the sodium-potassium pumps in muscle cells, leading to muscle weakness.
Management Strategies:
* Pacing: Carefully managing activity levels is critical to avoid triggering severe muscle fatigue and further muscle degradation.
* Nutritional Support: Maintaining adequate protein intake is crucial for preventing further muscle loss.
* Mobility Support: Using tools like wheelchairs or chairs (e.g., in the shower) can protect against overexertion, as discussed in this
The potential causes of myasthenia and fasciculations in severely ill ME patients: the role of disturbed electrophysiology: Skeletal muscle mitochondrial dysfunction can explain the loss of endurance and of force-endurance. However, a significant loss of force, even with the first muscular action after a sufficiently long rest, is not explained by a lack of energy due to mitochondrial dysfunction. This is because certain skeletal muscles are physiologically glycolytic, including the most vigorous muscles (which are made up of fast-twitch type 2b fibers).
References
https://www.frontiersin.org/…/fphys.2025.1693589/full
https://www.facebook.com/groups/1063785371126868/permalink/2004295510409178/?
https://pmc.ncbi.nlm.nih.gov/articles/PMC11671797/….
https://pmc.ncbi.nlm.nih.gov/articles/PMC4779819/
https://www.tandfonline.com/…/10…/21641846.2025.2556941
https://link.springer.com/article/10.1186/s12967-021-02833-2
#NightingaleContinuum
#GAMEICC

A young woman holds a protest sign outdoors, advocating for being heard.

Open Letter to the
Royal College of Psychiatrists

Dear Prof. Subodh Dave, President-elect, 12 May, 2026th
We are writing on ME Awareness Day in relation to the Royal College of Psychiatrists’
ongoing work on ME and Long Covid, and in the context of your stated commitment to
integrating patient expertise into clinical practice and institutional decision-making.
This commitment carries significant responsibility in conditions where patients have
experienced harm from mischaracterisation, delayed recognition, and the privileging of
theoretical psychosocial explanations in clinical and academic settings.
We are particularly concerned by the inclusion of speakers Paul Garner, Alan Carson, and
Trudie Chalder in Congress programming, given their longstanding association with
psychiatric-led psychosocial frameworks applied to ME, which continue to shape the
clinical interpretation of Long Covid.
While the programme includes biomedical terminology and references to patient
experience, its overall structure continues to position psychosocial and behavioural
frameworks as the primary lens through which post-acute viral illness is interpreted and
managed.
For example, cognitive symptoms and potential neurological markers are framed within a
psychiatric-led session; personal experience of post-infectious fatigue is presented
alongside psychological recovery narratives; and cognitive behavioural therapy is
positioned in relation to routine specialist clinic outcomes. This sequencing shapes how
evidence is interpreted and which explanatory models are implicitly centred.
The inclusion of biomedical language does not in itself reflect a shift in underlying
paradigm when interpretive authority remains organised around behavioural and
psychosocial models. In this context, patient experience is situated within frameworks that
determine its meaning in advance, rather than as an independent form of evidence.
Since the emergence of Long Covid, there has been a substantial expansion of biomedical
research documenting multi-system physiological dysfunction, alongside long-
established findings in ME. This includes immune dysregulation, autonomic dysfunction,
metabolic impairment, genetic findings from DecodeME and post-exertional malaise,
reflected in current NICE guideline NG206.
Against this backdrop, the continued prominence of proponents of psychosocially framed
models in defining how these conditions are presented risks misalignment with current
evidence and the emerging paradigm.
Open Letter to the
Royal College of Psychiatrists
longcovidadvoc.com
@LongCovidAdvoc
Long Covid Advocacy
We therefore ask that the Royal College:
Ensure Congress programming on ME and Long Covid reflects current biomedical
evidence and clinical guidance, and is not presented through outdated behavioural or
psychosocial models.
Review how speaker sequencing and session framing influence the interpretation of
evidence.
Ensure that patient expertise is positioned as an independent form of knowledge, not
subsumed within pre-existing theoretical models.
Align all teaching and outputs with NICE guideline NG206 and the current evidence
base on Long Covid, ensuring that psychological aspects of care do not supersede or
redefine the underlying biological condition.
These are not abstract concerns. The framing of these conditions directly influences
clinical reasoning, service design, and patient care pathways.
We urge the Royal College, under your incoming presidency, to take a clear leadership
position in ensuring that its programming reflects current understanding rather than
inherited psychosocial interpretive frameworks.
Yours sincerely,
longcovidadvoc.com
@LongCovidAdvoc
Mr Tomaso Antonacci
Natalie Boulton
Dr Harriet Carroll
Dr Leanne Curelli
Prof Todd Davenport
Mr Yanto Evans
Dr Peter Gordon
Dr Laura Gray
Dr Deepti Gurdasani
Dr Elke Hausmann
Assoc Prof Rupert Higham
Dr David Joffe
Prof Doug Kell
Dr Asad Khan
Mrs Beatrice Khouri
25% ME Group
Dutch Platform for MDs with IACC
Forward-ME
Hope 4 ME & Fibro Northern Ireland
Inclusive New Normal
Keyworker Petition Campaign (KWPC)
Lab of Lived Experience
Liberal Democrat Disability Association
Long Covid Physio
Long Covid Scotland
ME Action UK
ME Association
M.E Foggy Dog
Not Recovered UK
Physios for ME
Organisations Individuals
…/cont.
longcovidadvoc.com
@LongCovidAdvoc
Richmond, Kingston & West London ME Group
Scottish Healthcare Workers Coalition
#There4ME
WE&ME Foundation
Welsh Association of ME & CFS Support
Ms Elisabeth Klaar
Andrew Klaassen MD
Dr Marianne Lynch
Cass Macdonald
Dr Ben Marsh
Tom Molmens MD
Mr Michael Natt
Jolien Plantinga MD
Mrs Nicky Proctor
Dr Clare Rayner
Mr James Robertson
Dr Selina Shaw
Dr Charles Shepherd
Mrs Lindsay Skipper
Dr Nigel Speight
Dr Michael Stingl
Fen van Rhijn MD
Dr Joanne Van der Nagel
Dr Mark Vink
Mr Jonah Weisz
Organisations Individuals